Early Stage Combination Treatment with Methylprednisolone Pulse and Remdesivir for Severe COVID-19 Pneumonia

被引:2
作者
Mastruzzo, Claudio [1 ]
Commodari, Elena [2 ]
Grasso, Umberto [3 ]
La Rosa, Valentina Lucia [2 ]
Balsamo, Daniela [3 ]
Circo, Cristina [1 ]
Oliveri, Rosario [1 ]
机构
[1] Garibaldi Hosp, Dept Med, Unit Resp Dis, I-95124 Catania, Italy
[2] Univ Catania, Dept Educ Sci, I-95124 Catania, Italy
[3] Garibaldi Hosp, Dept Med, Unit Internal Med, I-95124 Catania, Italy
关键词
COVID-19; remdesivir; corticosteroids; pulse therapy; OUTCOMES; RATIO;
D O I
10.3390/ijerph20021081
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Background: This study evaluated the clinical outcomes of patients with severe COVID-19 pneumonia treated with remdesivir plus standard corticosteroid treatment (SCT) or with remdesivir plus high-dose corticosteroid pulse therapy (HDCPT). Methods: One hundred and two patients with severe COVID-19 pneumonia and respiratory failure were included. The patients were divided into two cohorts. The first comprised patients who received remdesivir and SCT, consisting of 6 mg dexamethasone daily for up to 10 days or until hospital discharge. The second included patients who received remdesivir and HDCPT, composed of 250 mg iv of methylprednisolone for three days, followed by a slow reduction in the dose of steroids. The severity of hypoxemia was assessed using the SaO2/FiO2 peripheral oxygen saturation index. Results: 55 received remdesivir plus HDCPT, and 47 received remdesivir plus SCT. Mortality at 30 days was significantly lower among patients who received remdesivir plus HDCPT (4/55) than among those who did not (15/47). In patients who received remdesivir plus HDCPT, 7.3% required invasive mechanical ventilation and admission to the ICU and 36.4% non-invasive ventilation versus 29.8% and 61.7%, respectively, among those treated with remdesivir plus SCT. Remdesivir plus HDCPT induced a significantly faster improvement in the SaO2/FiO2 index. Conclusion: Early combination treatment with remdesivir plus HDCPT reduced in-hospital mortality and the need for admission to the ICU. Furthermore, it improved the SaO2/FiO2 index faster in patients with severe COVID-19 pneumonia.
引用
收藏
页数:10
相关论文
共 27 条
[11]  
Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2022926, 10.1056/NEJMoa2021436]
[12]   Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [J].
Huang, Chaolin ;
Wang, Yeming ;
Li, Xingwang ;
Ren, Lili ;
Zhao, Jianping ;
Hu, Yi ;
Zhang, Li ;
Fan, Guohui ;
Xu, Jiuyang ;
Gu, Xiaoying ;
Cheng, Zhenshun ;
Yu, Ting ;
Xia, Jiaan ;
Wei, Yuan ;
Wu, Wenjuan ;
Xie, Xuelei ;
Yin, Wen ;
Li, Hui ;
Liu, Min ;
Xiao, Yan ;
Gao, Hong ;
Guo, Li ;
Xie, Jungang ;
Wang, Guangfa ;
Jiang, Rongmeng ;
Gao, Zhancheng ;
Jin, Qi ;
Wang, Jianwei ;
Cao, Bin .
LANCET, 2020, 395 (10223) :497-506
[13]   Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials [J].
Lai, Chih-Cheng ;
Chen, Chao-Hsien ;
Wang, Cheng-Yi ;
Chen, Kuang-Hung ;
Wang, Ya-Hui ;
Hsueh, Po-Ren .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (08) :1962-1968
[14]   High-dose corticosteroid pulse therapy increases the survival rate in COVID-19 patients at risk of hyper-inflammatory response [J].
Lopez Zuniga, Miguel Angel ;
Moreno-Moral, Aida ;
Ocana-Granados, Ana ;
Padilla-Moreno, Francisco Andres ;
Castillo-Fernandez, Alba Maria ;
Guillamon-Fernandez, Dionisio ;
Ramirez-Sanchez, Carolina ;
Sanchez-Palop, Maria ;
Martinez-Colmenero, Justo ;
Pimentel-Villar, Maria Amparo ;
Blazquez-Rosello, Sara ;
Moreno-Sanchez, Jose Juan ;
Lopez-Vilchez, Maria ;
Prior-Sanchez, Inmaculada ;
Jodar-Moreno, Rosario ;
Lopez Ruz, Miguel Angel .
PLOS ONE, 2021, 16 (01)
[15]  
National Institute for Health and Care Excellence, NICE guideline NG191
[16]  
National Institutes of Health, COR DIS 2019 TREATM
[17]   Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care [J].
Olender, Susan A. ;
Perez, Katherine K. ;
Go, Alan S. ;
Balani, Bindu ;
Price-Haywood, Eboni G. ;
Shah, Nirav S. ;
Wang, Su ;
Walunas, Theresa L. ;
Swaminathan, Shobha ;
Slim, Jihad ;
Chin, BumSik ;
De Wit, Stephane ;
Ali, Shamim M. ;
Viladomiu, Alex Soriano ;
Robinson, Philip ;
Gottlieb, Robert L. ;
Tsang, Tak Yin Owen ;
Lee, I-Heng ;
Hu, Hao ;
Haubrich, Richard H. ;
Chokkalingam, Anand P. ;
Lin, Lanjia ;
Zhong, Lijie ;
Bekele, B. Nebiyou ;
Mera-Giler, Robertino ;
Phulpin, Chloe ;
Edgar, Holly ;
Gallant, Joel ;
Diaz-Cuervo, Helena ;
Smith, Lindsey E. ;
Osinusi, Anu O. ;
Brainard, Diana M. ;
Bernardino, Jose, I .
CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) :E4166-E4174
[18]   Non-genomic Effects of Glucocorticoids: An Updated View [J].
Panettieri, Reynold A. ;
Schaafsma, Dedmer ;
Amrani, Yassine ;
Koziol-White, Cynthia ;
Ostrom, Rennolds ;
Tliba, Omar .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2019, 40 (01) :38-49
[19]   High-dose methylprednisolone in nonintubated patients with severe COVID-19 pneumonia [J].
Papamanoli, Aikaterini ;
Yoo, Jeanwoo ;
Grewal, Prabhjot ;
Predun, William ;
Hotelling, Jessica ;
Jacob, Robin ;
Mojahedi, Azad ;
Skopicki, Hal A. ;
Mansour, Mohamed ;
Marcos, Luis A. ;
Kalogeropoulos, Andreas P. .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 (02)
[20]   Comparison of the SpO2/FIO2 ratio and the Pao2/FIO2 ratio in patients with acute lung injury or ARDS [J].
Rice, Todd W. ;
Wheeler, Arthur P. ;
Bernard, Gordon R. ;
Hayden, Douglas L. ;
Schoenfeld, David A. ;
Ware, Lorraine B. .
CHEST, 2007, 132 (02) :410-417